Each ml contains Latanoprost 0.005% w/v Ophthalmic Solution.

Laprost Eye Drops contain Latanoprost 0.005%, a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma, ocular hypertension, and paediatric glaucoma. It effectively lowers intraocular pressure by increasing aqueous humour outflow through the uveoscleral pathway, helping reduce the risk of progressive optic nerve damage.

Laprost Eye Drops are indicated for the treatment of open-angle glaucoma and ocular hypertension, including the reduction of elevated intraocular pressure in paediatric patients with elevated intraocular pressure and paediatric glaucoma.

Latanoprost is a synthetic prostaglandin F2α analogue and a selective FP receptor agonist. It lowers intraocular pressure by increasing the uveoscleral outflow of aqueous humour without significantly affecting aqueous humour production. By reducing elevated intraocular pressure, Latanoprost helps protect the optic nerve and slow the progression of glaucomatous damage.

Instill one drop into the affected eye(s) once daily in the evening, or as directed by the physician.

Laprost Eye Drops are contraindicated in patients with known hypersensitivity to Latanoprost or any component of the formulation.